ArticleBMC cancer2020

Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells.

Hanhee Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.